Valuation: Becton, Dickinson and Company

Capitalization 49.36B 42.7B 40.06B 36.31B 67.03B 4,250B 75.82B 468B 182B 1,945B 185B 181B 7,107B P/E ratio 2025 *
28.8x
P/E ratio 2026 * 24.3x
Enterprise value 66.58B 57.6B 54.04B 48.98B 90.42B 5,732B 102B 632B 246B 2,624B 250B 245B 9,586B EV / Sales 2025 *
3.06x
EV / Sales 2026 * 2.81x
Free-Float
77.04%
Yield 2025 *
2.25%
Yield 2026 * 2.38%
More valuation ratios * Estimated data
Dynamic Chart
1 day-1.29%
1 week-0.71%
Current month-0.22%
1 month-0.03%
3 months-23.79%
6 months-23.65%
Current year-24.09%
More quotes
1 week 171.7
Extreme 171.7
176.33
1 month 167.94
Extreme 167.935
177.2
Current year 163.33
Extreme 163.33
251.98
1 year 163.33
Extreme 163.33
251.98
3 years 163.33
Extreme 163.33
287.32
5 years 163.33
Extreme 163.33
287.32
10 years 128.87
Extreme 128.87
287.32
More quotes
Manager TitleAgeSince
Chief Executive Officer 52 2020-01-27
Director of Finance/CFO 53 2021-09-05
Chief Tech/Sci/R&D Officer - 2021-11-28
Director TitleAgeSince
Director/Board Member 74 2002-09-23
Director/Board Member 70 2006-11-19
Director/Board Member 70 2010-07-25
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
-1.29%-0.71%-26.32%-27.27% 49.36B
-0.61%+1.53%+30.81%+29.41% 236B
-1.38%-0.19%+7.69%-2.33% 112B
+0.17%+2.28%+27.10%+107.67% 57.28B
-1.08%-1.38%-8.85%+32.85% 39.66B
-1.04%-5.40%-29.29%+14.66% 32.15B
-0.48%-0.59%+0.85%+35.06% 26.73B
-0.44%-0.98%+10.56%+19.31% 23.74B
-0.53%+2.01%+15.12%-31.65% 22.39B
+0.33%-2.29%+51.97%+49.12% 21.44B
Average -0.64%-0.17%+7.96%+22.68% 62.06B
Weighted average by Cap. -0.74%+0.48%+14.21%+24.19%
See all sector performances

Financials

2025 *2026 *
Net sales 21.77B 18.83B 17.67B 16.01B 29.56B 1,874B 33.44B 207B 80.36B 858B 81.7B 79.94B 3,134B 22.87B 19.78B 18.56B 16.82B 31.05B 1,969B 35.12B 217B 84.41B 901B 85.82B 83.97B 3,292B
Net income 1.81B 1.57B 1.47B 1.33B 2.46B 156B 2.78B 17.17B 6.68B 71.33B 6.79B 6.65B 261B 2.18B 1.89B 1.77B 1.6B 2.96B 188B 3.35B 20.68B 8.05B 85.93B 8.18B 8.01B 314B
Net Debt 17.22B 14.9B 13.98B 12.67B 23.39B 1,483B 26.45B 163B 63.57B 679B 64.64B 63.24B 2,479B 14.95B 12.94B 12.14B 11B 20.31B 1,288B 22.97B 142B 55.21B 589B 56.13B 54.92B 2,153B
More financial data * Estimated data
Logo Becton, Dickinson and Company
Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical management systems (49.8%): medication delivery systems, pharmaceutical systems, advanced patient monitoring systems, etc.; - diagnostic materials and clinical research and development tools (25.6%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, tools for studying genes and culturing cells, instruments for sorting and analyzing cells, monoclonal antibodies, etc.; - interventional medical equipment (24.6%): surgical instruments, urological care products, etc. Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
Employees
74,000
More about the company
Date Price Change Volume
25-06-13 172.21 $ -1.29% 2,276,369
25-06-12 174.46 $ +1.01% 1,664,351
25-06-11 172.72 $ -0.96% 2,361,041
25-06-10 174.39 $ +1.09% 2,922,265
25-06-09 172.51 $ -0.54% 3,447,564

Delayed Quote Nyse, June 13, 2025 at 04:00 pm

More quotes
Trading Rating
Investor Rating
ESG MSCI
BBB
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
172.21USD
Average target price
221.75USD
Spread / Average Target
+28.77%
Consensus

Quarterly revenue - Rate of surprise